Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Healthcare Agencies I

Healthcare Agencies I

Healthcare agencies provide healthcare services to people. In the United States, voluntary agencies are often non-profit centers sponsored by donations, grants, or fundraisers. One such organization is Meals on Wheels, which provides meals to the elderly and homebound. The American Heart Association and the American Lung Association are other non-profit community organizations. Doctors and nurses are frequently active members of these organizations, which offer health checks and educational...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Same author

Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.

Clinical pharmacology and therapeutics·2017

Same author

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.

Clinical pharmacology and therapeutics·2017

Same author

Food Effect Studies for Oncology Drug Products.

Clinical pharmacology and therapeutics·2017

Same author

Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.

Clinical pharmacology and therapeutics·2016

Same author

ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia.

The pharmacogenomics journal·2016

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Nonprofit biomedical companies.

R M Conti¹, D O Meltzer, M J Ratain

¹Department of Pediatrics, Section of Pediatric Hematology/Oncology, Center on Health and the Social Sciences, Program on Pharmaceutical Policy, Cancer Research Center, The University of Chicago, Chicago, Illinois, USA. rconti@uchicago.edu

Clinical Pharmacology and Therapeutics

|August 6, 2008

Summary

This summary is machine-generated.

Nonprofit biomedical firms offer market-based solutions for investing in high-social-value, low-profit scientific areas. Opportunities exist for nonprofit cancer diagnostic companies due to financing gaps and scientific potential.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Related Experiment Videos

Last Updated: Jul 3, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Area of Science:

Biomedical innovation
Health economics
Nonprofit organizations

Background:

Traditional for-profit models struggle with investments in areas of high social value but low profit potential.
Current market financing for innovative biomedical product development faces limitations.
There is a need for alternative investment structures in biomedical research.

Purpose of the Study:

To explore the role of nonprofit biomedical firms as market-based solutions.
To propose new nonprofit company models for health concerns in developed nations.
To identify specific opportunities for nonprofit ventures in biomedical product development.

Main Methods:

Review of the current biomedical investment market.
Analysis of financing incentives for innovative product development.
Conceptualization of new nonprofit firm structures.

Main Results:

Nonprofit biomedical firms can enhance incentives for investing in scientifically promising, socially valuable areas.
The current financing landscape presents challenges for certain high-impact biomedical innovations.
Specific opportunities are identified for nonprofit firms in developed countries' health sectors.

Conclusions:

Nonprofit biomedical firms represent a viable strategy to address market failures in biomedical investment.
New nonprofit models can be tailored to specific health concerns prevalent in developed countries.
Significant opportunities exist for nonprofit organizations focused on cancer diagnostics, leveraging scientific advancements and addressing financing limitations.